Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis

被引:46
作者
Girgis, N
Sultan, Y
Frenck, RW
El-Gendy, A
Farid, Z
Mateczun, A
机构
[1] USN, Med Res Unit 3, Clin Invest Branch, FPO, AE 09835 USA
[2] Abbassia Fever Hosp, Cairo, Egypt
关键词
azithromycin; rifampin; Neisseria meningitidis;
D O I
10.1097/00006454-199809000-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Objectives. To evaluate the efficacy and safety of azithromycin compared with rifampin for eradication of nasopharyngeal carriage of Neisseria meningitidis Methods. Pharyngeal swabs were obtained from 500 students attending nursing school in Cairo, Egypt, to determine the colonization rate with N. meningitidis. Colonized individuals were randomized to receive azithromycin (500 mg once) or rifampin (600 mg twice daily for four doses). Subjects were then recultured 1 and 2 weeks posttreatment to determine the effectiveness of the antibiotic therapy for eradication of meningococcal nasopharyngeal colonization. Results, Individuals treated with azithromycin had a 93% eradication rate at 1 and 2 weeks posttreatment comparable with 95 and 91%, respectively, for rifampin. No significant side effects were reported by any subjects treated with either antibiotic. Conclusion. Azithromycin is effective in the eradication of N, meningitidis from the nasopharynx of asymptomatic colonized individuals and deserves further evaluation for use as prophylaxis against N, meningitidis.
引用
收藏
页码:816 / 819
页数:4
相关论文
共 19 条
[1]
BAND JD, 1984, LANCET, V1, P101
[2]
INVITRO ACTIVITIES OF AZITHROMYCIN (CP-62,993), CLARITHROMYCIN (A-56268-TE-031), ERYTHROMYCIN, ROXITHROMYCIN, AND CLINDAMYCIN [J].
BARRY, AL ;
JONES, RN ;
THORNSBERRY, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :752-754
[3]
BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[4]
BEATY HN, 1983, REV INFECT DIS, V5, pS451
[5]
*CDCP, 1993, MMWR-MORBID MORTAL W, V42, P21
[6]
RIFAMPIN - LEVELS IN SERUM AND SALIVA AND EFFECT ON MENINGOCOCCAL CARRIER STATE [J].
DEVINE, LF ;
JOHNSON, DP ;
HAGERMAN, CR ;
PIERCE, WE ;
RHODE, SL ;
PECKINPAUGH, RO .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 214 (06) :1055-+
[7]
EVALUATION OF SINGLE-DOSE CIPROFLOXACIN IN THE ERADICATION OF NEISSERIA-MENINGITIDIS FROM NASOPHARYNGEAL CARRIERS [J].
DWORZACK, DL ;
SANDERS, CC ;
HOROWITZ, EA ;
ALLAIS, JM ;
SOOKPRANEE, M ;
SANDERS, WE ;
FERRARO, FM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1740-1741
[8]
CLINICAL EVALUATION OF GROUP-A AND GROUP-C MENINGOCOCCAL POLYSACCHARIDE VACCINES IN INFANTS [J].
GOLD, R ;
LEPOW, ML ;
GOLDSCHNEIDER, I ;
DRAPER, TL ;
GOTSCHLICH, EC .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (06) :1536-1547
[9]
GREENWOOD MM, 1978, BRIT MED J, V2, P1317
[10]
EFFECT OF RIFAMPIN AND MINOCYCLINE ON MENINGOCOCCAL CARRIER RATES [J].
GUTTLER, RB ;
COUNTS, GW ;
AVENT, CK ;
BEATY, HN .
JOURNAL OF INFECTIOUS DISEASES, 1971, 124 (02) :199-&